Back to ISMICS Main Site
 


Quick Links
   Home
Loading

 



Back to 2014 Annual Meeting Display Posters


APICAL OCCLUDER FOR PERCUTANEOUS TRANSAPICAL TAVR
Enrico Ferrari, Didier Locca, Siniscalchi Giuseppe, Denis Berdajs, René Prêtre, Piergiorgio Tozzi.
University Hospital CHUV, Lausanne, Switzerland.

OBJECTIVE: Transcatheter aortic valve replacement (TAVR) is an established technique for high risk patients with aortic valve stenosis. The Transapical approach is dedicated to patients with concomitant peripheral vascular disease. The development of valid apical occluder is the most important step towards full percutaneous transapical TAVR
METHODS: We employed an existing myocardial occluder and we modified its shape and its anchoring system to adapt the device to the new role: myocardial occluder for the apex in Transcatheter TAVR. First-in-human of the non-modified device (to confirm the feasibility) followed by animal tests with modified devices (2 designs).
RESULTS: The first-in-human use of teh non-modified VSD occluder after a TAVR using the Sapien platform was a successful case and confirmed that the procedure can be performed without pourse-string sutures. Animal tests are ongoing and preliminary results with the 2 different designs are promising. Data will be available beginning 2014.
CONCLUSIONS: Following the first human implant of an apical occluder for TAVR, and after the first animal experiences with modified devices, resuls appears very promising. A first step towards full-percutaneous TAVR.

Download ePoster


Back to 2014 Annual Meeting Display Posters
 
© 2026 International Society for Minimally Invasive Cardiothoracic Surgery. All Rights Reserved. Read Privacy Policy.